logo
  • PREVENTION
    • Sun Safety
    • Indoor Tanning
    • Early Detection
    • References
  • FIND A SPECIALIST
  • SQUAMOUS CELL SKIN CANCER
    • About
      • Overview
      • Images
      • Risk Factors
    • Diagnosis
    • Staging
      • High-Risk Features
      • A Practical Description
    • Treating
      • Treatment Options
      • Treatment By Stage
    • Living With
      • Secondary Prevention
      • Dealing With the Side Effects Of Therapy
    • Resources
  • BASAL CELL CARCINOMA
    • About
      • Overview
      • Images
      • Risk Factors
    • Diagnosis
    • Staging
      • High-Risk Features
      • A Practical Description
    • Treating
      • Treatment Options
      • By Stage
    • Living With
      • Secondary Prevention
      • Dealing With the Side Effects Of Therapy
    • Resources
  • MELANOMA
  • ASK AN EXPERT
  • ABOUT
  • PREVENTION
    • Sun Safety
    • Indoor Tanning
    • Early Detection
    • References
  • FIND A SPECIALIST
  • SQUAMOUS CELL SKIN CANCER
    • About
      • Overview
      • Images
      • Risk Factors
    • Diagnosis
    • Staging
      • High-Risk Features
      • A Practical Description
    • Treating
      • Treatment Options
      • Treatment By Stage
    • Living With
      • Secondary Prevention
      • Dealing With the Side Effects Of Therapy
    • Resources
  • BASAL CELL CARCINOMA
    • About
      • Overview
      • Images
      • Risk Factors
    • Diagnosis
    • Staging
      • High-Risk Features
      • A Practical Description
    • Treating
      • Treatment Options
      • By Stage
    • Living With
      • Secondary Prevention
      • Dealing With the Side Effects Of Therapy
    • Resources
  • MELANOMA
  • ASK AN EXPERT
  • ABOUT

The Skin Cancer Education and Research Foundation – Home › Forums › Intralesional immunotherapy › Infectious Precautions › TVEC infection control practices › Reply To: TVEC infection control practices

February 11, 2018 at 12:00 am #4673
Expert Nurse
Krista Rubin

Thanks!!

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2020 Skin Cancer Education & Research Foundation. All rights reserved.
  • News
  • Contact
  • Terms
  • Privacy